Skip to Main Content

INFORMATION FOR

    Michael S. Leapman, MD, MHS

    Associate Professor of Urology
    DownloadHi-Res Photo

    Are You a Patient?

    View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    View Doctor Profile

    Additional Titles

    Clinical Program Leader, Prostate & Urologic Cancers Program, Yale Cancer Center

    Assistant Professor, Chronic Disease Epidemiology

    About

    Titles

    Associate Professor of Urology

    Clinical Program Leader, Prostate & Urologic Cancers Program, Yale Cancer Center; Assistant Professor, Chronic Disease Epidemiology

    Biography

    Clinical interests: Prostate cancer: low-risk prostate cancer, active surveillance, nerve-sparing robotic prostatectomy, focal therapy, high-risk disease, pelvic lymph node dissection, imaging, risk stratification; molecular imaging; PSMA; focal therapy; bladder cancer: intravesical therapy, TURBT, radical cystectomy with urinary diversion, continent urinary diversion, neobladder, ileal conduit. Kidney cancer: laparoscopic radical nephrectomy, laparoscopic partial nephrectomy, robotic partial nephrectomy, open radical nephrectomy, open partial nephrectomy. Testicular cancer. Upper tract urothelial carcinoma: laparoscopic, open nephroureterectomy, ureterectomy Watch a video with Dr. Michael Leapman >>

    Michael Leapman, MD was drawn to the field of urology for the opportunity to care for patients with urologic cancers. He aims, above all, to deliver the highest level of care possible with the utmost consideration and compassion for the impact that cancer places on patients, as well as their families, friends and communities.

    Dr. Leapman graduated from Cornell University where he majored in Neurobiology and Behavior, and received his medical school degree from the University of Maryland in Baltimore. He completed his General Surgery and Urology training at the Mount Sinai Hospital in New York, NY. Subsequently, he completed a urologic oncology fellowship at the University of California San Francisco (UCSF) accredited by the Society of Urologic Oncology. He joined the faculty at the Yale University School of Medicine and Yale Cancer Center in 2016, specializing in urologic oncology with a joint appointment at the West Haven Veterans Affairs Medical Center.

    Appointments

    Other Departments & Organizations

    Education & Training

    MHS
    Yale University (2022)
    Fellowship
    University of California San Francisco (2016)
    Residency
    Mount Sinai Medical Center (2014)
    Internship
    Mount Sinai Medical Center (2010)
    MD
    University of Maryland School of Medicine (2009)
    BA
    Cornell University (2005)

    Research

    Overview

    Medical Research Interests

    Delivery of Health Care; Health Services Research; Kidney Diseases; Prostatic Neoplasms; Ureteral Diseases; Urinary Bladder Diseases; Urologic Neoplasms

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Michael S. Leapman's published research.

    Publications

    2024

    Clinical Trials

    Academic Achievements & Community Involvement

    • honor

      John N. Forrest Jr. Prize for Mentorship in Student Research

    • honor

      Best Poster

    • honor

      Merit Award

    • honor

      First Place Essay, History Section

    • honor

      Outstanding Abstract Selected for Oral Presentation

    Clinical Care

    Overview

    Michael S. Leapman, MD, who specializes in prostate, bladder, testicular and kidney cancers, loves his work as a urologic oncologist.

    “Every day, I have the ability to make a difference in a patient's life,” says Dr. Leapman. “It's a tremendous honor and responsibility, and it's very rewarding.”

    A member of Yale Cancer Center, he sees patients at Smilow Cancer Hospital and the West Haven Veteran’s Administration. An assistant professor of urology at Yale School of Medicine, he studies the best treatments for prostate cancer and how gene expression signatures can predict the aggressiveness of this cancer.

    “Hearing the emotionally wrought words ‘it’s cancer’ is extremely difficult to navigate,” he says. “So that's one of the issues that we are sensitive to, and continue to strive to improve.”

    The patient-physician bond is essential in helping patients with prostate cancer, for example, to choose which kind of treatment is best: surgery, radiation therapy or active surveillance, an ongoing monitoring of what can be a slow-progressing disease.

    “It really is a very special relationship between a urologist and a patient. I have found that the team at Yale is 100 percent invested in the outcomes of our patients, and we stand out by seeking to understand their concerns, goals by being there for them every step of the way.”

    Clinical Specialties

    Urology; Urologic Oncology

    Fact Sheets

    Board Certifications

    • Urology

      Certification Organization
      AB of Urology
      Original Certification Date
      2018

    Yale Medicine News

    Get In Touch

    Contacts

    Appointment Number
    Clinical Inquiry Number
    Mailing Address

    Urology

    PO Box 208058

    New Haven, CT 06520-8058

    United States

    Locations

    • Patient Care Locations

      Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    Events

    Mar 202527Thursday